×
About 1,450 results

ALLMedicine™ Central Retinal Vein Occlusion Center

Research & Reviews  463 results

Impending central retinal vein occlusion and granulomatous uveitis in a patient with Sa...
https://doi.org/10.1097/MD.0000000000033284
Medicine Saima Y, Tanaka Y et. al.

Mar 18th, 2023 - Satoyoshi syndrome is a rare systemic autoimmune disease that presents with painful muscle spasms. We report a case of impending central retinal vein occlusion (CRVO) secondary to granulomatous pan-uveitis in a 32-year-old woman with Satoyoshi syn...

Two-year outcomes of patients presenting to Sydney Eye Hospital with neovascular glaucoma.
https://doi.org/10.1007/s10792-023-02675-5
International Ophthalmology; Kingston EJ, Lusthaus JA

Mar 14th, 2023 - Neovascular glaucoma (NVG) is a sight-threatening condition that is often refractory to treatment. Current management principles are yet to be standardized due to lack of evidence. We studied the interventions used to treat NVG at Sydney Eye Hospi...

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion
https://clinicaltrials.gov/ct2/show/NCT04740931

Feb 28th, 2023 - This is a Phase III, multicenter, randomized, double-masked, active comparator-controlled, parallel-group study evaluating the efficacy, safety, and pharmacokinetics of faricimab administered by intravitreal (IVT) injection at 4-week intervals unt...

Macular Edema in Central Retinal Vein Occlusion Correlates With Aqueous Fibrinogen Alph...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970003
Investigative Ophthalmology & Visual Science; Cehofski LJ, Kojima K et. al.

Feb 24th, 2023 - The global protein profile of the aqueous humor has been found to correlate with the severity of retinal vascular disease. Studying the aqueous humor in central retinal vein occlusion (CRVO) with proteomic techniques may bring insights to the mole...

Bilateral central retinal vein occlusion as an initial presentation of Waldenström macr...
https://doi.org/10.1186/s13256-023-03778-4
Journal of Medical Case Reports; Shrestha S, Poddar E et. al.

Feb 23rd, 2023 - Waldenström macroglobulinemia is a rare hematological malignancy and is the most common diagnosis in patients with hyperviscosity syndrome. Bilateral central retinal vein occlusion as an initial presentation of hyperviscosity syndrome in Waldenstr...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  76 results

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion
https://clinicaltrials.gov/ct2/show/NCT04740931

Feb 28th, 2023 - This is a Phase III, multicenter, randomized, double-masked, active comparator-controlled, parallel-group study evaluating the efficacy, safety, and pharmacokinetics of faricimab administered by intravitreal (IVT) injection at 4-week intervals unt...

Study to Gather Information on the Safety and Use of Aflibercept Injections Into the Eye for the Treatment of Eye Disorders in Mexican Routine Clinical Practice
https://clinicaltrials.gov/ct2/show/NCT04137120

Feb 17th, 2023 - The primary objective is to assess the safety of intravitreal aflibercept injections in patients with wet age-related macular degeneration (wAMD), myopic choroidal neovascularization (mCNV), diabetic macular edema (DME), macular edema secondary to...

Treatment of Central Retinal Vein Occlusion Using Stem Cells Study
https://clinicaltrials.gov/ct2/show/NCT03981549

Feb 15th, 2023 - The goal of this phase I/II prospective, randomized, sham-controlled, double-masked clinical trial is to determine whether intravitreal autologous CD34+ stem cell therapy is safe, feasible and potentially beneficial in eyes with vision loss from c...

Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion
https://clinicaltrials.gov/ct2/show/NCT03810313

Jan 30th, 2023 - The study included Screening Period (Day -28 to Day -1), double-masked treatment period (Day 1 to Week 72), and post-treatment follow-up period (Week 72 to Week 76). Treatment visits were scheduled in 4-week intervals. After 6 initial monthly inje...

Connection Between Periodontitis and Exudative Age-related Macular Degeneration
https://clinicaltrials.gov/ct2/show/NCT03958461

Jan 30th, 2023 - Periodontitis is a chronic low-grade bacterial infection of supporting tissue of teeth. Chronic periodontitis is often non symptomatic. Inflammation is located usually in deepened periodontal pockets (> 4mm or >6mm) and it leads to alveolar bone l...

see more →

News  39 results

Non-Paxlovid Rebound; Pandemic Spike in Early Puberty; New Therapy for Nightmares?
https://www.medpagetoday.com/infectiousdisease/covid19/101470

Oct 28th, 2022 - Note that some links may require subscriptions. Outpatient COVID treatment with nirmatrelvir-ritonavir (Paxlovid) was 36% and 30% lower for Black and Hispanic patients compared with white patients, a CDC report found. A high proportion of recovere...

FDA OKs Aflibercept (Eylea) for Diabetic Retinopathy
https://www.medscape.com/viewarticle/913006

May 14th, 2019 - The US Food and Drug Administration (FDA) has approved aflibercept (Eylea, Regeneron) injection solution to treat all stages of diabetic retinopathy, the manufacturer has announced. Aflibercept, a vascular endothelial growth factor (VEGF) inhibito...

FDA Okays Aflibercept (Eylea) for Diabetic Retinopathy
https://www.staging.medscape.com/viewarticle/913006

May 14th, 2019 - The US Food and Drug Administration (FDA) has approved aflibercept (Eylea, Regeneron Pharmaceuticals) injection solution to treat all stages of diabetic retinopathy, the manufacturer has announced. Aflibercept, a vascular endothelial growth factor...

Sustained Drug-Delivery Tech Shows Promise
https://www.medpagetoday.com/ophthalmology/generalophthalmology/69384

Nov 19th, 2017 - Development of technologies for sustained drug delivery is a topic of great interest among retina specialists, considering the number of chronic conditions that are managed with repeated intravitreal injections. Products in this category are alrea...

An Elderly Patient's Blurry Right Eye Raises Questions
https://www.medscape.com/viewarticle/882951_2

Jul 24th, 2017 - Case Diagnosis Isolated chronic elevation of the optic disc with relatively preserved visual function raises suspicion for vitreopapillary traction (VPT). This diagnosis can be confirmed by OCT, as it was in this patient. Idiopathic intracranial h...

see more →

Patient Education  1 results see all →